The Technical Analyst
Select Language :
Pulmonx Corporation [LUNG]

Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices

Pulmonx Corporation Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: SELL (auto-tracking)

Pulmonx Corporation is listed at the  Exchange

1.76% $9.27

America/New_York / 28 mar 2024 @ 16:00


Pulmonx Corporation: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 357.24 mill
EPS: -1.600
P/E: -5.79
Earnings Date: Apr 30, 2024
SharesOutstanding: 38.54 mill
Avg Daily Volume: 0.483 mill
RATING 2024-03-28
B
Neutral
RATINGS
Rating CashFlow: Strong Sell
Return On Equity: Sell
Return On Asset: Neutral
DE: Buy
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -5.79 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.03x
Company: PE -5.79 | industry: PE 222.16
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 8.67 - 9.87

( +/- 6.52%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-22 Rose Geoffrey Beran Sell 1 184 Common Stock
2024-03-15 Williamson Steven S. Buy 425 116 Employee Stock Option (right to buy)
2024-03-15 Williamson Steven S. Buy 205 286 Common Stock
2024-03-15 Williamson Steven S. Buy 0
2024-03-01 Rose Geoffrey Beran Buy 69 100 Common Stock
INSIDER POWER
78.10
Last 99 transactions
Buy: 1 791 475 | Sell: 224 262

Forecast: 16:00 - $9.27

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $9.27
Forecast 2: 16:00 - $9.27
Forecast 3: 16:00 - $9.27
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $9.27 (1.76% )
Volume 0.583 mill
Avg. Vol. 0.483 mill
% of Avg. Vol 120.67 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Pulmonx Corporation

Last 12 Months

Last 12 months chart data with high, low, open and close for Pulmonx Corporation

RSI

Intraday RSI14 chart for Pulmonx Corporation

Last 10 Buy & Sell Signals For LUNG

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35sell$14.32N/AActive
Profile picture for
            Pulmonx Corporation

LUNG

Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Last 10 Buy Signals

Date Signal @
CTXUSDMar 29 - 06:194.96
FUMOUSDMar 29 - 06:149 999
ORCAUSDMar 29 - 06:143.79
ORAIUSDMar 29 - 06:0714.49
FRAXUSDMar 29 - 06:08$0.996
CAHUSDMar 29 - 06:0737.41
BARUSDMar 29 - 06:083.56
XAUTUSDMar 29 - 06:08$2 231.46
STORJUSDMar 29 - 06:07$0.802
YAKUSDMar 29 - 06:04829.07

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.